Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	93610
Country	China

Received	2024-03-02 03:59
Peer-Review Started	2024-03-02 03:59
To Make the First Decision
Return for Revision	2024-08-17 19:51
Revised	2024-08-29 07:56
Second Decision	2024-09-05 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-05 07:15
Articles in Press	2024-09-05 07:15
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-11 00:42
Publish the Manuscript Online	2024-09-26 10:17

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Letter to the Editor
Article Title	Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges
Manuscript Source	Invited Manuscript
All Author List	Yan-Fei He
ORCID	Author(s) ORCID Number Yan-Fei He http://orcid.org/0000-0003-4689-5068
Funding Agency and Grant Number
Corresponding Author	Yan-Fei He, MD, Associate Chief Physician, Doctor, Doctor, Department of Health Management Center, The Sixth Medical Center, Chinese People’s Liberation Army General Hospital, NO. 6 Fucheng Road, Haidian District, Beijing 100048, China. heyanfeilc@163.com
Key Words	Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy
Core Tip	This letter reviews recent advances in conversion therapy for hepatocellular carcinoma (HCC), comparatively describes the characteristics of different conversion programs, addresses current challenges in conversion therapy, highlights the complexity of conversion therapy for moderately advanced HCC, and emphasizes the importance of a multidisciplinary, team-based management model, and provides valuable insights into the treatment of unresectable HCC.
Publish Date	2024-09-26 10:17
Citation	<p>He YF. Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges. <i>World J Gastrointest Oncol</i> 2024; 16(10): 4289-4297</p>
URL	https://www.wjgnet.com/1948-5204/full/v16/i10/4289.htm
DOI	https://dx.doi.org/10.4251/wjgo.v16.i10.4289

Full Article (PDF)	WJGO-16-4289-with-cover.pdf
Manuscript File	93610_Auto_Edited_035243.docx
Answering Reviewers	93610-answering-reviewers.pdf
Audio Core Tip	93610-audio.mp3
Conflict-of-Interest Disclosure Form	93610-conflict-of-interest-statement.pdf
Copyright License Agreement	93610-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	93610-non-native-speakers.pdf
Peer-review Report	93610-peer-reviews.pdf
Scientific Misconduct Check	93610-scientific-misconduct-check.png
Scientific Editor Work List	93610-scientific-editor-work-list.pdf
CrossCheck Report	93610-crosscheck-report.png
CrossCheck Report	93610-crosscheck-report.pdf